首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2rγnull humanized mice
【2h】

Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2rγnull humanized mice

机译:在表达HLA I类NOD / SCID /IL2rγnull人源化小鼠的HLA I类中具有HLA限制性免疫应答的功能性人类T细胞亚群的生成

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Whereas humanized mouse models have contributed significantly to human immunology research, human T cells developing in mouse thymic environment fail to demonstrate HLA-restricted function. To achieve HLA-restricted human immune response, we created an immune-compromised non-obese diabetic/SCID/IL2rgnull strain (NSG) with homozygous expression of HLA class I heavy chain and light chain (NSG-HLA-A2/HHD). Transplantation of purified Lin−CD34+CD38− human hematopoietic stem cells into NSG-HLA-A2/HHD newborns resulted in the development of human CD4+ and CD8+ TCRαβ+ T cells and CD4−CD8− and CD8+ TCRγδ+ cells in recipient bone marrow and spleen. Human cytotoxic T lymphocytes (CTLs) become functionally mature, as evidenced by the production of granzyme corresponding to phenotypic transition from naïve to effector memory CTLs. In these recipients, human Th17 cells developed along with Th1 and Th2 cells. Epstein–Barr virus (EBV) infection in the humanized NSG-HLA-A2/HHD recipients resulted in the formation of lymphoproliferative lesions consisting mainly of human B cells with scattered human T cells. Human CTLs developing in the recipients recognized EBV-derived peptides in an HLA-restricted manner and exerted HLA-restricted cytotoxicity against EBV-infected human B cells. The HLA-expressing humanized mouse with functional HLA-restricted T cells and consistent representation of rare T-cell subsets overcomes a major constraint in human immunology, and serves as a useful model for investigation of human immune responses against pathogens and for the development of therapeutic strategies against human diseases.
机译:尽管人源化的小鼠模型对人类免疫学研究做出了重要贡献,但是在小鼠胸腺环境中发育的人类T细胞未能证明HLA限制的功能。为了实现HLA限制的人类免疫应答,我们创建了一种免疫受损的非肥胖型糖尿病/ SCID / IL2rg null 菌株(NSG),其HLA I类重链和轻链(NSG- HLA-A2 / HHD)。将纯化的Lin-CD34 + CD38-人类造血干细胞移植到NSG-HLA-A2 / HHD新生儿中,导致人类CD4 +和CD8 +TCRαβ+ T细胞以及CD4-CD8-和CD8 +TCRγδ+细胞在受体和脾。人类细胞毒性T淋巴细胞(CTL)在功能上已经成熟,这与相应的表型从幼稚CTL到效应记忆CTL的粒酶生成有关。在这些受体中,人类Th17细胞与Th1和Th2细胞一起发育。人源化NSG-HLA-A2 / HHD受体中的爱泼斯坦-巴尔病毒(EBV)感染导致形成淋巴增生性病变,主要由人B细胞和散布的人T细胞组成。在受体中发育的人类CTL以HLA限制的方式识别EBV衍生的肽,并对EBV感染的人类B细胞发挥HLA限制的细胞毒性。具有HLA限制性功能性T细胞且一致表达稀有T细胞亚型的表达HLA的人源化小鼠克服了人类免疫学的一个主要限制,并成为研究人类针对病原体的免疫反应和开发治疗性疾病的有用模型应对人类疾病的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号